BIIB129

BIIB129 is a brain-penetrant, covalent BTK inhibitor used for research into B-cell driven pathologies. It is employed in both in vitro and in vivo studies to investigate mechanisms of B-cell proliferation and related autoimmune or oncological diseases.

Product Specifications

CAS Number

2770960-52-4

Product Name Alternative

BIIB 129

Field of Research

Cardiovascular Research, Signal Transduction

Purity

98.56% (May vary between batches)

Solubility

DMSO:80 mg/mL (218.33 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (9.01 mM)

Smiles

O (C=1C=2N (C=C (N1) C3=CN (C) N=C3) N=CC2) [C@@]4 (C) C[C@@H] (N (C (C=C) =O) C) C4

Molecular Formula

C19H22N6O2

Molecular Weight

366.42

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

MBS6442790-01 0.1 mL

USP48 (Ubiquitin-specific Processing Protease 48, USP31, RAP1GA1) (FITC)

View Details

MBS6442790-02 5x 0.1 mL

USP48 (Ubiquitin-specific Processing Protease 48, USP31, RAP1GA1) (FITC)

View Details

124040-HRP 100 µL

BTF3 (Transcription Factor BTF3, RNA Polymerase B Transcription Factor 3, NACB, OK/SW-cl.8) (HRP)

View Details

ABP-S-04409 5 Plates

Human DEFA3 Matched Antibody Pair Set [ABP-S-04409]

View Details

NBP2-99174PCP 0.1 mL

Rabbit Polyclonal APOBEC3B Antibody [PerCP]

View Details

K2502306 1.0 µg DNA

TRNAL25 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

View Details